Abcellera Biologics (ABCL.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov7

Abcellera Biologics released FY2025 9 Months Earnings on November 6 After-Market EST, with actual revenue of USD 30.27 M and EPS of USD -0.4643

00:00

Abcellera Biologics released FY2025 Q3 earnings on November 6 After-Market EST, actual revenue USD 8.955 M (forecast USD 6.333 M), actual EPS USD -0.1911 (forecast USD -0.1725)

00:00

Oct30

Abcellera Biologics to Release FY2025 Q3 Earnings on November 6 After-Market (EST), Forecast Revenue USD 6.333 M, EPS USD -0.1725

00:11

Aug7

Abcellera Biologics released FY2025 Q2 earnings on August 7 After-Market EST, actual revenue USD 17.08 M (forecast USD 6.36 M), actual EPS USD -0.1199 (forecast USD -0.1616)

23:00

Abcellera Biologics released FY2025 Semi-Annual Earnings on August 7 After-Market (EST), with actual revenue of USD 21.32 M and EPS of USD -0.2699

23:00

Jul31

Abcellera Biologics to Release FY2025 Q2 Earnings on August 7 After-Market EST, Forecast Revenue USD 6.36 M, EPS USD -0.1616

00:12